MyoKardia’s MYK-491 shows favourable profile in Phase Ia study
MyoKardia has reported positive data from the Phase Ia clinical trial of MYK-491 in healthy...
Read More...
Focus:
Greece
-
M&As this week: Cosmos Holdings, Akebia Therapeutics, Biogen
Cosmos Holdings has signed a share purchase agreement to acquire 100% interest in Cosmofarm Ltd...
Read More...